Stefano De Nart
About Stefano De Nart
Stefano De Nart serves as the Chairman and Co-Founder of Elysium Lab, a financial technology platform based in Lugano, Switzerland. He has a background in financial risk management and ESG analysis, along with experience in both the legal and financial sectors.
Work at Elysium Lab
Stefano De Nart serves as the Chairman and Co-Founder of Elysium Lab, a company established in 2023 in Lugano, Canton Ticino, Switzerland. Elysium Lab is recognized for its innovative approach to financial technology, positioning itself as a transformative platform that connects current financial practices with future advancements. Under his leadership, the company aims to redefine the landscape of financial services through technology-driven solutions.
Education and Expertise
Stefano De Nart has a strong educational background in finance and risk management. He studied at MIP-Politecnico Di Milano, where he earned a Master di 2 livello in Financial Risk Management from 2017 to 2018. In 2023, he completed a program in ESG Analysis & Investing at OCP Academy. His education supports his extensive experience in both the legal and financial sectors, enhancing his multifaceted expertise.
Background
Before co-founding Elysium Lab, Stefano De Nart held a position as Partner at Kreston RS s.r.l. from 2019 to 2020 in Milano, Italia. His career reflects a blend of legal and financial roles, contributing to his comprehensive understanding of the industry. Currently, he also works as Counsel at MDS Legal Tax in Milano, Lombardia, Italia, further solidifying his presence in the legal sector.
Achievements
Stefano De Nart co-founded Elysium Lab, which aims to serve as a bridge between current financial practices and future innovations in financial technology. His leadership role in the company highlights his commitment to advancing the financial technology landscape. His educational pursuits in financial risk management and ESG analysis further demonstrate his dedication to professional growth and industry relevance.